Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
28.31
+0.72 (2.61%)
Nov 11, 2025, 1:39 PM EST - Market open
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.7 billion as of November 11, 2025. Its market cap has decreased by -36.92% in one year.
Market Cap
1.70B
Enterprise Value
734.05M
1-Year Change
-36.92%
Ranking
Category
Stock Price
$28.31
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.70B, an increase of 177.45%. That is a compound annual growth rate of 26.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.59B | -48.40% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 863.15B |
| Johnson & Johnson | 451.14B |
| AbbVie | 384.91B |
| UnitedHealth Group | 290.00B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.29B |
| Abbott Laboratories | 218.45B |
| Thermo Fisher Scientific | 216.16B |